142
Participants
Start Date
December 9, 2020
Primary Completion Date
October 4, 2021
Study Completion Date
October 12, 2021
BLU-5937
Oral administration of BLU-5937 tablets
Placebo
Oral administration of matching placebo for BLU-5937 tablets
Bellus Health Investigational Site #34, New York
Bellus Health Investigational Site #37, Newtown Square
Bellus Health Investigational Site #14, High Point
Bellus Health Investigational Site #24, Savannah
Bellus Health Investigational Site #15, Hialeah
Bellus Health Investigational Site #32, Margate
Bellus Health Investigational Site #16, Miami
Bellus Health Investigational Site #19, Miami
Bellus Health Investigational Site #17, Sweetwater
Bellus Health Investigational Site #13, Owensboro
Bellus Health Investigational Site #36, Minneapolis
Bellus Health Investigational Site #41, Rapid City
Bellus Health Investigational Site #18, New Orleans
Bellus Health Investigational Site #45, Covington
Bellus Health Investigational Site #38, Baton Rouge
Bellus Health Investigational Site #29, Norman
Bellus Health Investigational Site #31, College Station
Bellus Health Investigational Site #40, San Antonio
Bellus Health Investigational Site #11, San Antonio
Bellus Health Investigational Site #12, Austin
Bellus Health Investigational Site #28, Phoenix
Bellus Health Investigational Site #10, Scottsdale
Bellus Health Investigational Site #23, Beverly Hills
Bellus Health Investigational Site #33, Encinitas
Bellus Health Investigational Site #35, San Diego
Bellus Health Investigational Site #27, Fountain Valley
Bellus Health Investigational Site #25, Seattle
Bellus Health Investigational Site #22, Portsmouth
Bellus Health Investigational Site #44, Chicoutimi
Bellus Health Investigational Site #20, Montreal
Bellus Health Investigational Site #43, Québec
Bellus Health Investigational Site #39, Québec
Bellus Health Investigational Site #42, Sherbrooke
Bellus Health Inc. - a GSK company
INDUSTRY